TME Pharma Announces Successful Advice Meeting With US Food And Drug Administration On NOX-A12 Development In Brain Cancer
Constructive meeting held with FDA provided feedback and clear guidance on key aspects of further development of NOX…
Constructive meeting held with FDA provided feedback and clear guidance on key aspects of further development of NOX…
Messenger RNA (mRNA) nanomedicines, a ground-breaking technology that has led to the development of the first approved C…
Die Medigene AG (Medigene, FWB: MDG1, Prime Standard), ein Unternehmen, das sich auf die Entdeckung und Entwicklung von…
Die Medigene AG (Medigene oder das "Unternehmen", FWB: MDG1, Prime Standard), ein immunonkologisches Plattformunternehme…
Europe's leading provider of AI software for pathology, Mindpeak (Hamburg), has announced groundbreaking work with leadi…
The field of medical innovation is constantly evolving, and new breakthroughs are being made regularly. It's always a go…
Preclinical data published in Frontiers in Immunology, a leading peer-reviewed journal Induction of pro-inflammatory…
Apogenix, a biopharmaceutical company developing next generation immunotherapeutics, announced today that its partner CA…
As part of this year's BioTech Bootcamp of BioM Biotech Cluster GmbH and the life science business incubator "SmiLe Incu…
Allero Therapeutics BV, a Dutch oromucosal immunotherapy company, today announced that the Company has received a EUR 2.…